Markes Receives Two Queen's Awards
Markes International has been awarded two Queen’s Awards for Enterprise in the categories of “innovation” and “international trade”.
Markes International (Llantrisant, Wales, UK) has been awarded two Queen’s Awards for Enterprise in the categories of “innovation” and “international trade”. The awards stemmed from Markes’ new valving technology, which is incorporated into all its thermal desorption instruments, as well as its continued growth in overseas trade.
The switch-valve that is the subject of the innovation award was developed and patented by the company and allows routine monitoring of a wide range of volatile and semivolatile organic compounds, by virtue of its tolerance of temperature extremes, small size, quick operation, and construction from inert materials.
“Precise, reproducible control of gas flows is vital for the successful operation of any thermal desorption instrument,” said Alun Cole, Founding Director of Markes International.
This is the second time Markes has been awarded a Queen’s Award for “international trade”; they received their first in
2015.
“Looking back at the 20 years Markes has been in business, it’s fair to say that innovations have been central to our achievements. We always have been, and continue to be, an innovative company, and are therefore very proud to have received these Queen’s Awards. These stand as testament to our excellence in analytical chemistry-both in our technical innovation, as well as our success in satisfying our customers globally,” said Cole.
For more information, please visit: www.markes.com
AI and GenAI Applications to Help Optimize Purification and Yield of Antibodies From Plasma
October 31st 2024Deriving antibodies from plasma products involves several steps, typically starting from the collection of plasma and ending with the purification of the desired antibodies. These are: plasma collection; plasma pooling; fractionation; antibody purification; concentration and formulation; quality control; and packaging and storage. This process results in a purified antibody product that can be used for therapeutic purposes, diagnostic tests, or research. Each step is critical to ensure the safety, efficacy, and quality of the final product. Applications of AI/GenAI in many of these steps can significantly help in the optimization of purification and yield of the desired antibodies. Some specific use-cases are: selecting and optimizing plasma units for optimized plasma pooling; GenAI solution for enterprise search on internal knowledge portal; analysing and optimizing production batch profitability, inventory, yields; monitoring production batch key performance indicators for outlier identification; monitoring production equipment to predict maintenance events; and reducing quality control laboratory testing turnaround time.
2024 EAS Awardees Showcase Innovative Research in Analytical Science
November 20th 2024Scientists from the Massachusetts Institute of Technology, the University of Washington, and other leading institutions took the stage at the Eastern Analytical Symposium to accept awards and share insights into their research.
